MARKET

AKYA

AKYA

Akoya Biosciences, Inc.
NASDAQ
3.810
-0.090
-2.31%
Closed 16:00 04/23 EDT
OPEN
3.880
PREV CLOSE
3.900
HIGH
4.000
LOW
3.800
VOLUME
85.66K
TURNOVER
0
52 WEEK HIGH
8.80
52 WEEK LOW
3.040
MARKET CAP
187.23M
P/E (TTM)
-2.6735
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AKYA last week (0415-0419)?
Weekly Report · 1d ago
Weekly Report: what happened at AKYA last week (0408-0412)?
Weekly Report · 04/15 09:01
Piper Sandler Keeps Their Buy Rating on Akoya Biosciences (AKYA)
TipRanks · 04/09 11:06
Weekly Report: what happened at AKYA last week (0401-0405)?
Weekly Report · 04/08 09:01
Bullish Akoya Biosciences Insider Buying Worth US$2.11m Yet To Pay Off
Akoya Biosciences, Inc. Insiders bought US$2.11m worth of shares at an average price of US$4.98 in the past 12 months. The company's share price has fallen 10% in the last year. Akoya Bio's insiders own about 5.6% of the company. It's important to pay attention to whether insiders are buying or selling shares. The biggest insider purchase was by Matthew Winkler for US$1.0m in the same year.
Simply Wall St · 04/05 10:18
Weekly Report: what happened at AKYA last week (0325-0329)?
Weekly Report · 04/01 09:01
Weekly Report: what happened at AKYA last week (0318-0322)?
Weekly Report · 03/25 09:01
Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader
Cytek Biosciences is a leading cellular analysis instrument maker with a focus on the Aurora flow cytometry platform. Despite a downturn in the healthcare market, Cytek has maintained revenue growth above 15% since IPO. Cytek's technological advantage, broadening ecosystem, and potential in the clinical and biopharma space contribute to the positive outlook.
Seeking Alpha · 03/20 08:33
More
About AKYA
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).

Webull offers Akoya Biosciences Inc stock information, including NASDAQ: AKYA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKYA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKYA stock methods without spending real money on the virtual paper trading platform.